Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2021

View Archived Issues

rVSV-deltaG-spike vaccine protects hamsters against SARS-CoV-2 challenge

Forma begins phase II/III study of FT-4202 in sickle cell disease

Viralym-M enters phase III for virus-associated hemorrhagic cystitis

Dyne reports preclinical data from DM1 program

Chinese investigators divulge EGFR inhibitors

Nanjing Greepharma patents new ARG1 inhibitors

Shanghai Institute of Materia Medica discloses PRDX1 inhibitors

Hawaii Biotech identified new botulinum neurotoxin inhibitors

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Turning Point Therapeutics describes new RET inhibitors

Antibody protects broadly against flaviviruses, without ADE

A humanized mouse HIV latency model to test HIV cure strategies

Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A

Identification of small-molecule HNC-0014 as a multi-targeted immunotherapy lead compound for HNSCC

New heterocyclic ring systems as a novel class of brain-penetrating V1A antagonists

Chipscreen Biosciences submits IND to the NMPA for pivotal phase III study of chiauranib in SCLC

Leishmania parasites trigger SHP-1, which acts as a negative regulator of antigen cross-presentation

Axcella provides development updates for its lead candidates

European Commission approves Roclanda ophthalmic solution

Promising data presented from phase II study of rifamycin SV-MMX in IBS-D

Gannex reports phase I data on ASC-41 supporting progression for NASH

Helsinn begins phase I/II study of oral RET inhibitor TAS-0953 in advanced solid tumors

CureVac reports NHP data on COVID-19 vaccine candidate CVnCoV

New trial investigates use of NAC for IPF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...